HWKN earnings analysis
What we found in HWKN's 10-K: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Hawkins, Inc. reported solid growth in fiscal 2026 with total sales of $1,083.7 million, marking an 11% increase from the previous year, driven primarily by the Water Treatment segment which saw a 22% growth. Despite increased sales, diluted EPS decreased slightly to $3.91 due to rising costs, particularly in materials and interest expenses, reflecting the company's ongoing efforts to navigate a competitive environment while pursuing strategic acquisitions to enhance its product portfolio and market reach.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Record Revenue Growth
- Total sales reached $1,083.7 million in fiscal 2026, an increase of 11% from $974.4 million in fiscal 2025.
- Strong Water Treatment Performance
- Sales in the Water Treatment segment increased by 22%, contributing $543.3 million to overall sales.
- Increased Operating Cash Flow
- Operating cash flow rose by 30% to $144.3 million, up from $111.1 million in fiscal 2025.
- Successful Acquisitions
- Acquisitions contributed approximately $83.3 million to sales in the Water Treatment segment.
- Improved Gross Margins
- Gross profit increased by 9% to $245.1 million, maintaining a gross margin of 22.6%.
- Continued Dividend Payments
- The company declared cash dividends totaling $15.7 million in fiscal 2026, up from $14.6 million in 2025.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Increased Interest Expense
- Interest expense surged to $13.5 million in fiscal 2026, up from $5.4 million in fiscal 2025, due to higher debt from acquisitions.
- Competitive Pricing Pressures
- The Food and Health Sciences segment faced a slight sales decline amid competitive pricing pressures, decreasing 1% to $320.7 million.
- Dependence on Commodity Prices
- Fluctuations in raw material costs remain a risk, impacting gross margins amid rising expenses.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $3.91
- Gross margin
- 22.6%
- Operating margin
- 11.2%
- Segment
- Water Treatment
- Segment
- Food and Health Sciences
- Segment
- Industrial Solutions
What they said about what is next.
Guidance for fiscal 2027 emphasizes continued revenue growth, capitalizing on recent acquisitions and improving operational efficiency.
The filing reads about the same as the one before it.
What came before.
- 10-Q · January 29, 2025
- Hawkins reported Q3 sales of $226.205M (up $17.709M or +8.5% YoY) with gross profit of $48.424M and diluted EPS of $0.72. Water Treatment was the driver, growing to $99.752M while Industrial declined slightly to…
- 10-Q · July 31, 2024
- Hawkins reported quarterly sales of $255,879,000, up modestly from $251,120,000 a year ago, with substantial margin expansion driving operating income to $39,791,000 and diluted EPS to $1.38. All three segments posted…
- 10-Q · February 1, 2023
- Hawkins reported quarterly sales of $219.218M, up $32.168M (+17.2%) versus $187.050M a year earlier, with diluted EPS of $0.51 versus $0.48 prior year. Revenue growth was broad-based (Industrial and Water Treatment) but…
- 10-Q · August 4, 2022
- Hawkins reported strong top-line growth in Q1: revenue rose to $246.543M from $181.241M (+$65.302M) and diluted EPS increased to $0.94 from $0.79 (+$0.15). Margin mix shifted: gross margin declined to 19.0% from 21.5%…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing HWKN makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever